Codexis Inc (NASDAQ: CDXS) kicked off on Monday, up 3.06%% from the previous trading day, before settling in for the closing price of $2.29. Over the past 52 weeks, CDXS has traded in a range of $1.90-$6.08.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Annual sales at Healthcare sector company slipped by -33.31% over the past five years. While this was happening, its average annual earnings per share was recorded 22.15%. With a float of $80.17 million, this company’s outstanding shares have now reached $82.84 million.
Let’s look at the performance matrix of the company that is accounted for 188 employees. In terms of profitability, gross margin is 69.08%, operating margin of -134.4%, and the pretax margin is -149.4%.
Codexis Inc (CDXS) Insider Updates
Our next focus will be how large-scale investors are participating in this stock of the Biotechnology Industry. The insider ownership of Codexis Inc is 3.23%, while institutional ownership is 83.15%. The most recent insider transaction that took place on Jun 12 ’25, was worth 225,000. In this transaction 10% Owner of this company bought 100,000 shares at a rate of $2.25, taking the stock ownership to the 12,100,000 shares. Before that another transaction happened on Jun 13 ’25, when Company’s 10% Owner bought 99,102 for $2.23, making the entire transaction worth $220,997. This insider now owns 12,199,102 shares in total.
Codexis Inc (CDXS) Performance Highlights and Predictions
Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.11 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 22.15% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 41.30% during the next five years compared to -33.31% drop over the previous five years of trading.
Codexis Inc (NASDAQ: CDXS) Trading Performance Indicators
Take a look at Codexis Inc’s (CDXS) current performance indicators. Last quarter, stock had a quick ratio of 3.64. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 3.93.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -0.99, a number that is poised to hit -0.19 in the next quarter and is forecasted to reach -0.57 in one year’s time.
Technical Analysis of Codexis Inc (CDXS)
Codexis Inc (NASDAQ: CDXS) saw its 5-day average volume 0.68 million, a negative change from its year-to-date volume of 0.84 million. As of the previous 9 days, the stock’s Stochastic %D was 48.17%.
During the past 100 days, Codexis Inc’s (CDXS) raw stochastic average was set at 16.55%, which indicates a significant decrease from 56.03% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 49.44% in the past 14 days, which was lower than the 85.61% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $2.35, while its 200-day Moving Average is $3.42. Nevertheless, the first resistance level for the watch stands at $2.42 in the near term. At $2.47, the stock is likely to face the second major resistance level. The third major resistance level sits at $2.57. If the price goes on to break the first support level at $2.27, it is likely to go to the next support level at $2.17. Assuming the price breaks the second support level, the third support level stands at $2.12.
Codexis Inc (NASDAQ: CDXS) Key Stats
The company with the Market Capitalisation of 195.51 million has total of 82,845K Shares Outstanding. Its annual sales at the moment are 59,350 K in contrast with the sum of -65,280 K annual income. Company’s last quarter sales were recorded 7,540 K and last quarter income was -20,690 K.
